Rare Disease Diagnostics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hematology
1.2.3 Oncology
1.3 Market by Application
1.3.1 Global Rare Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Diagnostics Market Perspective (2017-2028)
2.2 Rare Disease Diagnostics Growth Trends by Region
2.2.1 Rare Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rare Disease Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Rare Disease Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Rare Disease Diagnostics Market Dynamics
2.3.1 Rare Disease Diagnostics Industry Trends
2.3.2 Rare Disease Diagnostics Market Drivers
2.3.3 Rare Disease Diagnostics Market Challenges
2.3.4 Rare Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Diagnostics Players by Revenue
3.1.1 Global Top Rare Disease Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Rare Disease Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Rare Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Diagnostics Revenue
3.4 Global Rare Disease Diagnostics Market Concentration Ratio
3.4.1 Global Rare Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Diagnostics Revenue in 2021
3.5 Rare Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Rare Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Rare Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Diagnostics Breakdown Data by Type
4.1 Global Rare Disease Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Rare Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Rare Disease Diagnostics Breakdown Data by Application
5.1 Global Rare Disease Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Rare Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rare Disease Diagnostics Market Size (2017-2028)
6.2 North America Rare Disease Diagnostics Market Size by Type
6.2.1 North America Rare Disease Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Rare Disease Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Rare Disease Diagnostics Market Share by Type (2017-2028)
6.3 North America Rare Disease Diagnostics Market Size by Application
6.3.1 North America Rare Disease Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Rare Disease Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Rare Disease Diagnostics Market Share by Application (2017-2028)
6.4 North America Rare Disease Diagnostics Market Size by Country
6.4.1 North America Rare Disease Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Rare Disease Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Rare Disease Diagnostics Market Size (2017-2028)
7.2 Europe Rare Disease Diagnostics Market Size by Type
7.2.1 Europe Rare Disease Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Rare Disease Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Rare Disease Diagnostics Market Share by Type (2017-2028)
7.3 Europe Rare Disease Diagnostics Market Size by Application
7.3.1 Europe Rare Disease Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Rare Disease Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Rare Disease Diagnostics Market Share by Application (2017-2028)
7.4 Europe Rare Disease Diagnostics Market Size by Country
7.4.1 Europe Rare Disease Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Rare Disease Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Disease Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Rare Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Rare Disease Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rare Disease Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Rare Disease Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Rare Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Rare Disease Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rare Disease Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Rare Disease Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Rare Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Rare Disease Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rare Disease Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rare Disease Diagnostics Market Size (2017-2028)
9.2 Latin America Rare Disease Diagnostics Market Size by Type
9.2.1 Latin America Rare Disease Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Rare Disease Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Rare Disease Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Rare Disease Diagnostics Market Size by Application
9.3.1 Latin America Rare Disease Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Rare Disease Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Rare Disease Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Rare Disease Diagnostics Market Size by Country
9.4.1 Latin America Rare Disease Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Rare Disease Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Disease Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Rare Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Rare Disease Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rare Disease Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Rare Disease Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Rare Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Rare Disease Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rare Disease Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Rare Disease Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Rare Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Rare Disease Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rare Disease Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Retrophin
11.1.1 Retrophin Company Details
11.1.2 Retrophin Business Overview
11.1.3 Retrophin Rare Disease Diagnostics Introduction
11.1.4 Retrophin Revenue in Rare Disease Diagnostics Business (2017-2022)
11.1.5 Retrophin Recent Developments
11.2 3billion
11.2.1 3billion Company Details
11.2.2 3billion Business Overview
11.2.3 3billion Rare Disease Diagnostics Introduction
11.2.4 3billion Revenue in Rare Disease Diagnostics Business (2017-2022)
11.2.5 3billion Recent Developments
11.3 23andMe
11.3.1 23andMe Company Details
11.3.2 23andMe Business Overview
11.3.3 23andMe Rare Disease Diagnostics Introduction
11.3.4 23andMe Revenue in Rare Disease Diagnostics Business (2017-2022)
11.3.5 23andMe Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Rare Disease Diagnostics Introduction
11.4.4 QIAGEN Revenue in Rare Disease Diagnostics Business (2017-2022)
11.4.5 QIAGEN Recent Developments
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Rare Disease Diagnostics Introduction
11.5.4 Illumina Revenue in Rare Disease Diagnostics Business (2017-2022)
11.5.5 Illumina Recent Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Rare Disease Diagnostics Introduction
11.6.4 PerkinElmer Revenue in Rare Disease Diagnostics Business (2017-2022)
11.6.5 PerkinElmer Recent Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Diagnostics Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2017-2022)
11.7.5 Strand Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rare Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Hematology
Table 3. Key Players of Oncology
Table 4. Global Rare Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Rare Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Rare Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Rare Disease Diagnostics Market Share by Region (2017-2022)
Table 8. Global Rare Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Rare Disease Diagnostics Market Share by Region (2023-2028)
Table 10. Rare Disease Diagnostics Market Trends
Table 11. Rare Disease Diagnostics Market Drivers
Table 12. Rare Disease Diagnostics Market Challenges
Table 13. Rare Disease Diagnostics Market Restraints
Table 14. Global Rare Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Rare Disease Diagnostics Revenue Share by Players (2017-2022)
Table 16. Global Top Rare Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2021)
Table 17. Ranking of Global Top Rare Disease Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Rare Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Disease Diagnostics Product Solution and Service
Table 21. Date of Enter into Rare Disease Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Rare Disease Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Rare Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Rare Disease Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Rare Disease Diagnostics Revenue Share by Application (2017-2022)
Table 29. Global Rare Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Rare Disease Diagnostics Revenue Share by Application (2023-2028)
Table 31. North America Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Rare Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Rare Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Rare Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Rare Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Rare Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Rare Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Rare Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Rare Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Rare Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Rare Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Rare Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Rare Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Rare Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Rare Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Rare Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Rare Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Rare Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Rare Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Rare Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Rare Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Rare Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Rare Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Retrophin Company Details
Table 62. Retrophin Business Overview
Table 63. Retrophin Rare Disease Diagnostics Product
Table 64. Retrophin Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Retrophin Recent Developments
Table 66. 3billion Company Details
Table 67. 3billion Business Overview
Table 68. 3billion Rare Disease Diagnostics Product
Table 69. 3billion Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 70. 3billion Recent Developments
Table 71. 23andMe Company Details
Table 72. 23andMe Business Overview
Table 73. 23andMe Rare Disease Diagnostics Product
Table 74. 23andMe Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 75. 23andMe Recent Developments
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Rare Disease Diagnostics Product
Table 79. QIAGEN Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 80. QIAGEN Recent Developments
Table 81. Illumina Company Details
Table 82. Illumina Business Overview
Table 83. Illumina Rare Disease Diagnostics Product
Table 84. Illumina Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Illumina Recent Developments
Table 86. PerkinElmer Company Details
Table 87. PerkinElmer Business Overview
Table 88. PerkinElmer Rare Disease Diagnostics Product
Table 89. PerkinElmer Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 90. PerkinElmer Recent Developments
Table 91. Strand Life Sciences Company Details
Table 92. Strand Life Sciences Business Overview
Table 93. Strand Life Sciences Rare Disease Diagnostics Product
Table 94. Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 95. Strand Life Sciences Recent Developments
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Hematology Features
Figure 3. Oncology Features
Figure 4. Global Rare Disease Diagnostics Market Share by Application: 2021 VS 2028
Figure 5. Hospital Laboratories Case Studies
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Genetic Testing Laboratories Case Studies
Figure 8. Cancer Research Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Rare Disease Diagnostics Report Years Considered
Figure 11. Global Rare Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Rare Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Rare Disease Diagnostics Market Share by Region: 2021 VS 2028
Figure 14. Global Rare Disease Diagnostics Market Share by Players in 2021
Figure 15. Global Top Rare Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Diagnostics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Rare Disease Diagnostics Revenue in 2021
Figure 17. North America Rare Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Rare Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 19. North America Rare Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 20. North America Rare Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 21. United States Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Rare Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Rare Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Rare Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Rare Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 27. Germany Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Rare Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Rare Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Rare Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Rare Disease Diagnostics Market Size Share by Region (2017-2028)
Figure 37. China Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Rare Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Rare Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Rare Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Rare Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 47. Mexico Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Rare Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Rare Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Rare Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Rare Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 53. Turkey Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Rare Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Retrophin Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 57. 3billion Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 58. 23andMe Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 59. QIAGEN Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 60. Illumina Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 61. PerkinElmer Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 62. Strand Life Sciences Revenue Growth Rate in Rare Disease Diagnostics Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
